Reaktion #1783391
ord-69ae7562c45c4eee91699db68128471f
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1workup.STIRRINGstirred at ambient temperature for overnight
- 2Extraktionextracted with EtOAc and tetrahydrofuran
- 3WaschenThe organic layer was washed with brine
- 4Trocknendried over MgSO4
- 5Sonstigeevaporated in vacuo
- 6SonstigeThe residue was purified by praparative thin layer chromatography
- 7Wascheneluting with dichloromethane
- 8workup.ADDITIONThe fractions containing desired compound
- 9Sonstigeevaporated
- 10workup.DISSOLUTIONThe residue was dissolved in dioxane (500 μl)
- 11workup.ADDITION1M NaOH solution (352 μl) was added
- 12workup.STIRRINGstirred at 100° C. for 2 hours
- 13TemperaturAfter cooling to the ambient temperature, 1M HCl (352 μl) and pH 4 buffer (10 ml)
- 14workup.ADDITIONwas added to the reaction mixture
- 15SonstigeResulting
- 16Sonstigeprecipitates
- 17Filtrationwere collected by filtration
- 18Waschenwashed with water
Vorschrift
To a suspension of sodium hydride (60% in oil) (15 mg) in tetrahydrofuran (1 ml) was added dropwise ethyl(diethoxyphosphoryl)acetate (84 μl). After stirring at ambient temperature for 5 minutes, cis-3-(2-oxo-3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(2H)-yl)cyclohexanecarbaldehyde (100 mg) was added and stirred at ambient temperature for overnight. The reaction mixture was poured into water, and extracted with EtOAc and tetrahydrofuran. The organic layer was washed with brine, dried over MgSO4 and evaporated in vacuo. The residue was purified by praparative thin layer chromatography eluting with dichloromethane:methanol=10:1. The fractions containing desired compound were combined and evaporated. The residue was dissolved in dioxane (500 μl), and 1M NaOH solution (352 μl) was added, then stirred at 100° C. for 2 hours. After cooling to the ambient temperature, 1M HCl (352 μl) and pH 4 buffer (10 ml) was added to the reaction mixture. Resulting precipitates were collected by filtration and washed with water to give (2E)-3-[cis-3-(2-oxo-3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(2H)-yl)cyclohexyl]acrylic acid (21 mg) as a yellow powder.